Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
We dig into newly released Phase 2b data from Pfizers once-monthly GLP-1 candidate (formerly Metseras asset), what the results actually show, and how it stacks up in an increasingly crowded field that includes Novo Nordisk, Eli Lilly, and next-gen combination therapies
(2022) Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial Chao Liao, et al
$199.99 Frmula Molecular: C62H98N16O22 Peso Molecular: 1419.54 g/mol Frmula Molecular: C14H24N6O4Cu Peso Molecular: 403.86 g/mol Frmula Molecular: C212H350N56O78S Peso Molecular: 4963.49 g/mol Frmula Molecular: C16H30N4O5 Peso Molecular: 358.44 g/mol Components: BPC-157 (C62H98N16O22, 1419.54 g/mol) GHK-Cu (C14H24N6O4Cu, 403.86 g/mol) TB-500 (C212H350N56O78S, 4963.49 g/mol) KPV (C16H30N4O5, 358.44 g/mol) There are no reviews yet.
Gerogianni A, Dimitrov JD, Zarantonello A, Poillerat V, Chonat S, Sandholm K, et al
Eur J Clin Pharmacol 35:157160 Herd B, Wynne H, Wright P, James O, Woodhouse K (1991) The effect of age on glucuronidation and sulphation of paracetamol by human liver fractions
US$ 27.68
US$ 26.68
US$ 27.96
US$ 22.22
